The Scientist

» PCR, immunology and disease/medicine

Most Recent

image: Cannabis Catch-All?

Cannabis Catch-All?

By | June 20, 2012

Researchers in the U.K. are looking to breed marijuana to make medicines for metabolic disorders, epilepsy, and other diseases.


image: Opinion: On the Up and Up

Opinion: On the Up and Up

By | June 20, 2012

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.


image: Chronic Fatigue Case Dropped

Chronic Fatigue Case Dropped

By | June 15, 2012

The criminal charges that had been brought upon chronic fatigue syndrome researcher Judy Mikovits for stealing data from her former employer have been dropped.

1 Comment

image: Manipulating Eggs to Avoid Disease

Manipulating Eggs to Avoid Disease

By | June 13, 2012

A United Kingdom ethics council approves altering human egg cells, which could allow doctors to correct mitochondrial disease in IVF patients.


image: Questioning the HIV Cure

Questioning the HIV Cure

By | June 12, 2012

Sensitive tests reveal the Berlin patient believed to be cured of HIV still carries HIV RNA and antibodies.


image: African Cholera Vaccine Trial

African Cholera Vaccine Trial

By | June 12, 2012

For the first time, an oral cholera vaccine is used to control an active epidemic of the bacterial disease.


image: Older Dads Have Healthier Kids?

Older Dads Have Healthier Kids?

By | June 11, 2012

New research finds that older men have children and grandchildren with longer telomeres, possibly pointing to health benefits of delayed reproduction.


image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Naturally Resistant HIV Foils Therapy

Naturally Resistant HIV Foils Therapy

By | June 8, 2012

New computational modeling suggests pre-existing HIV drug resistance mutations may contribute more to drug failure than previously thought.


image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.


LI-COR Biosciences
LI-COR Biosciences

Popular Now

  1. Inside a Lab Mouse’s High-Fat Diet
  2. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

  3. How Gastric Bypass Can Kill Sugar Cravings
  4. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

Life Technologies